Legal & General Group Plc Boosts Stake in Thermo Fisher Scientific Inc.

The institutional investor increased its position in the medical research company by 5.3% in the third quarter.

Mar. 10, 2026 at 11:11am

Got story updates? Submit your updates here. ›

Legal & General Group Plc, an institutional investor, raised its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 5.3% in the third quarter, according to a disclosure filed with the Securities and Exchange Commission. The firm now owns 2,462,988 shares of the medical research company's stock, valued at $1,194,598,000 at the end of the quarter.

Why it matters

Thermo Fisher Scientific is a major player in the medical research industry, providing scientific instrumentation, reagents, and other products and services to laboratories worldwide. The increase in Legal & General Group's stake signals continued investor confidence in the company's performance and growth prospects.

The details

According to the filing, Legal & General Group Plc acquired an additional 124,432 shares of Thermo Fisher Scientific during the third quarter, bringing its total position to 2,462,988 shares. This represents approximately 0.66% of the medical research company's outstanding stock.

  • Legal & General Group Plc increased its stake in Thermo Fisher Scientific in the third quarter of 2026.

The players

Legal & General Group Plc

A British multinational financial services company that provides insurance, pension management, and other investment products.

Thermo Fisher Scientific Inc.

An American biotechnology company that provides scientific instrumentation, reagents, and other products and services to the medical research industry.

Got photos? Submit your photos here. ›

The takeaway

The increase in Legal & General Group's stake in Thermo Fisher Scientific reflects the continued investor confidence in the medical research company's performance and growth prospects, despite broader market volatility.